BeOne Medicines
ONC
#821
Rank
โ‚น2.863 T
Marketcap
โ‚น27,596
Share price
2.02%
Change (1 day)
31.36%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): โ‚น434.74

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is โ‚น456.56. In 2025 the company made an earnings per share (EPS) of โ‚น259.13 an increase over its 2024 EPS that were of -โ‚น592.29.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น434.7467.77%
2025โ‚น259.13-143.75%
2024-โ‚น592.29
2022-โ‚น1,85128.21%
2021-โ‚น1,444-19.96%
2020-โ‚น1,80420.81%
2019-โ‚น1,49331.52%
2018-โ‚น1,135417.57%
2017-โ‚น219.34-37.16%
2016-โ‚น349.06158.95%
2015-โ‚น134.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น22.78-104.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น90.17-119.75%๐Ÿ‡บ๐Ÿ‡ธ USA